Cited by 612Antifungal resistance and susceptibilityAntimicrobial agents and applicationsLipid Membrane Structure and Behavior

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Amphotericin primarily kills yeast by simply binding ergosterol

Open access

Gray, Kaitlyn C., Palacios, Daniel S., Dailey, Ian, Endo, Matthew M., Uno, Brice E., Wilcock, Brandon C., Burke, Martin D.·2012·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1117280109PMC PMC3289339

Open this paper in CoChat — free account Open PDF

Abstract

Amphotericin B (AmB) is a prototypical small molecule natural product that can form ion channels in living eukaryotic cells and has remained refractory to microbial resistance despite extensive clinical utilization in the treatment of life-threatening fungal infections for more than half a century. It is now widely accepted that AmB kills yeast primarily via channel-mediated membrane permeabilization. Enabled by the iterative cross-coupling-based synthesis of a functional group deficient derivative of this natural product, we have discovered that channel formation is not required for potent fungicidal activity. Alternatively, AmB primarily kills yeast by simply binding ergosterol, a lipid that is vital for many aspects of yeast cell physiology. Membrane permeabilization via channel formation represents a second complementary mechanism that further increases drug potency and the rate of yeast killing. Collectively, these findings ( i ) reveal that the binding of a physiologically important microbial lipid is a powerful and clinically validated antimicrobial strategy that may be inherently refractory to resistance, ( ii ) illuminate a more straightforward path to an improved therapeutic index for this clinically vital but also highly toxic antifungal agent, and ( iii ) suggest that the capacity for AmB to form protein-like ion channels might be separable from its cytocidal effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1117280109

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry
Ejsing, C. S., Sampaio, J. L., Surendranath, V., Duchoslav, E., Ekroos, K., Klemm, R. W., Simons, K., & Shevchenko, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811700106 · Cited by 1,053
Antibacterial agents based on the cyclic d,l-α-peptide architecture
Fernandez‐Lopez, S., Kim, H.-S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A. B., Kraehenbuehl, K., Long, G. V., Weinberger, D. A., Wilcoxen, K., et al. (2001) · Nature · doi:10.1038/35086601 · Cited by 938
The Bacteria Fight Back
Taubes, G. (2008) · Science · doi:10.1126/science.321.5887.356 · Cited by 757
How do the polyene macrolide antibiotics affect the cellular membrane properties?
Bolard, J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(86)90002-x · Cited by 757
Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. III. Molecular structure of the polyene antibiotic-cholesterol complexes
KRUIJFF, B. D., & DEMEL, R. A. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90332-0 · Cited by 609
A General Solution for Unstable Boronic Acids: Slow-Release Cross-Coupling from Air-Stable MIDA Boronates
Knapp, D. M., Gillis, E. P., & Burke, M. D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901416p · Cited by 559
Self-citation
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, L., Hillman, J. D., Zachariah, C., Kuipers, O. P., KRUIJFF, B. D., & Breukink, E. J. (2006) · Science · doi:10.1126/science.1129818 · Cited by 502
A Simple and Modular Strategy for Small Molecule Synthesis: Iterative Suzuki−Miyaura Coupling of B-Protected Haloboronic Acid Building Blocks
Gillis, E. P., & Burke, M. D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0716204 · Cited by 488
Self-citation

Show all 50 references

Sorted by citations

Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Ponte‐Sucre, A., Gamarro, F., Dujardin, J., Barrett, M. P., López‐Vélez, R., García‐Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006052 · Cited by 971
Candida auris: Epidemiology, biology, antifungal resistance, and virulence
Du, H., Bing, J., Hu, T., Ennis, C. L., Nobile, C. J., & Huang, G. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008921 · Cited by 609
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
Synthesis of many different types of organic small molecules using one automated process
Li, J., Ballmer, S. G., Gillis, E. P., Fujii, S., Schmidt, M., Ray, A. M. E. P., Lehmann, J. W., Morehouse, G. F., & Burke, M. D. (2015) · Science · doi:10.1126/science.aaa5414 · Cited by 545
Self-citation
Cryptococcus: from environmental saprophyte to global pathogen
May, R. C., Stone, N. R. H., Wiesner, D. L., Bicanic, T., & Nielsen, K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.6 · Cited by 541
Amphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528
Self-citation
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Cavassin, F. B., Baú-Carneiro, J. L., Boas, R. R. V., & Queiroz‐Telles, F. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00382-7 · Cited by 403
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Dijck, P. V. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 387
Antimicrobial Peptides: An Update on Classifications and Databases
Hafeez, A. B., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 367
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
“Its potent fungicidal activity derives from its ability to selectively bind the major sterol of fungal membranes, ergosterol [7,8].”
Background
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Mesa-Arango, A. C., Scorzoni, L., & Zaragoza, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00286 · Cited by 311
Multifunctional antimicrobial materials: From rational design to biomedical applications
Duan, S., Wu, R., Xiong, Y., Ren, H., Lei, C., Zhao, Y., Zhang, X., & Xu, F. (2021) · Progress in Materials Science · doi:10.1016/j.pmatsci.2021.100887 · Cited by 260
Recent advances and new strategies on leishmaniasis treatment
Roatt, B. M., Cardoso, J. M. D. O., de Brito, R. C. F., Coura‐Vital, W., Aguiar‐Soares, R. D. D. O., & Reis, A. B. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10856-w · Cited by 274
The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
Mesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232
Antimicrobial Peptides: a New Frontier in Antifungal Therapy
Cesare, G. B. D., Cristy, S. A., Garsin, D. A., & Lorenz, M. C. (2020) · mBio · doi:10.1128/mbio.02123-20 · Cited by 248
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
Li, K., Schurig-Briccio, L. A., Feng, X., Upadhyay, A., Pujari, V., Lechartier, B., Fontes, F. L., Yang, H., Rao, G., Zhu, W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500131s · Cited by 224
A brief history of antibiotics and select advances in their synthesis
Nicolaou, K. C., & Rigol, S. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.62 · Cited by 224
Synthesis of most polyene natural product motifs using just 12 building blocks and one coupling reaction
Woerly, E. M., Roy, J., & Burke, M. D. (2014) · Nature Chemistry · doi:10.1038/nchem.1947 · Cited by 210
Self-citation
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Faustino, C. M. C., & Pinheiro, L. M. V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010029 · Cited by 211
Cryptococcus neoformans, a global threat to human health
Zhao, Y., Ye, L., Zhao, F., Zhang, L., Lu, Z., Chu, T., Wang, S., Liu, Z., Sun, Y., Chen, M., et al. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01073-4 · Cited by 217
The Molecular Industrial Revolution: Automated Synthesis of Small Molecules
Trobe, M., & Burke, M. D. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201710482 · Cited by 198
Self-citation
New Horizons in Antifungal Therapy
Pianalto, K. M., & Alspaugh, J. A. (2016) · Journal of Fungi · doi:10.3390/jof2040026 · Cited by 197
Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance
Alcázar‐Fuoli, L., & Mellado, E. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00439 · Cited by 187
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda
Smith, K. D., Achan, B., Hullsiek, K. H., McDonald, T. R., Okagaki, L. H., Alhadab, A. A., Akampurira, A., Rhein, J., Meya, D. B., Boulware, D. R., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01299-15 · Cited by 191
Solid-State NMR Investigations of Extracellular Matrixes and Cell Walls of Algae, Bacteria, Fungi, and Plants
Ghassemi, N., Poulhazan, A., Deligey, F., Mentink‐Vigier, F., Marcotte, I., & Wang, T. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00669 · Cited by 190
Reactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
The Aspergillus fumigatus cell wall integrity signaling pathway: drug target, compensatory pathways, and virulence
Valiante, V., Macheleidt, J., Föge, M., & Brakhage, A. A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00325 · Cited by 189
From Synthesis to Function via Iterative Assembly of N-Methyliminodiacetic Acid Boronate Building Blocks
Li, J., Grillo, A. S., & Burke, M. D. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00128 · Cited by 183
Self-citation
Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
Kamiński, D. M. (2014) · European Biophysics Journal · doi:10.1007/s00249-014-0983-8 · Cited by 182
Characterization of the sterol 14α‐demethylases of Fusarium graminearum identifies a novel genus‐specific CYP 51 function
Fan, J., Urban, M., Parker, J. E., Brewer, H. C., Kelly, S. L., Hammond-Kosack, K. E., FRAAIJE, B. A., Liu, X., & Cools, H. J. (2013) · New Phytologist · doi:10.1111/nph.12193 · Cited by 178
Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy
Wall, G., & Lopez-Ribot, J. L. (2020) · Antibiotics · doi:10.3390/antibiotics9080445 · Cited by 183
Targeting Candida albicans filamentation for antifungal drug development
Vila, T., Romo, J. A., Pierce, C. G., McHardy, S. F., Saville, S. P., & Lopez-Ribot, J. L. (2017) · Virulence · doi:10.1080/21505594.2016.1197444 · Cited by 174
The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles
Walker, L. A., Sood, P., Lenardon, M. D., Milne, G., Olson, J. A., Jensen, G. M., Wolf, J. M., Casadevall, A., Adler‐Moore, J., & Gow, N. A. R. (2018) · mBio · doi:10.1128/mbio.02383-17 · Cited by 170
New facets of antifungal therapy
Chang, Y.-L., Yu, S.-J., Heitman, J., Wellington, M. A., & Chen, Y. (2016) · Virulence · doi:10.1080/21505594.2016.1257457 · Cited by 173
New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics
Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 162
Drug resistance in eukaryotic microorganisms
Fairlamb, A. H., Gow, N. A. R., Matthews, K. R., & Waters, A. P. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.92 · Cited by 153
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
Yang, S., & Kar, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100011 · Cited by 162
Towards the generalized iterative synthesis of small molecules
Lehmann, J. W., Blair, D. J., & Burke, M. D. (2018) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0115 · Cited by 156
Self-citation
The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus
Furukawa, T., van Rhijn, N., Fraczek, M. G., Gsaller, F., Davies, E. A., Carr, P. D., Gago, S., Fortune‐Grant, R., Rahman, S., Gilsenan, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14191-1 · Cited by 133
Combatting the evolution of antifungal resistance in Cryptococcus neoformans
Bermas, A., & Geddes‐McAlister, J. (2020) · Molecular Microbiology · doi:10.1111/mmi.14565 · Cited by 143
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 141
Emerging New Targets for the Treatment of Resistant Fungal Infections
Liu, N., Tu, J., Dong, G., Wang, Y., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01413 · Cited by 129
Selvamicin, an atypical antifungal polyene from two alternative genomic contexts
Arnam, E. B. V., Ruzzini, A. C., Sit, C. S., Horn, H. A., Pinto‐Tomás, A. A., Currie, C. R., & Clardy, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613285113 · Cited by 127
The Future of Antifungal Drug Therapy: Novel Compounds and Targets
Mota Fernandes, C., Dasilva, D., Haranahalli, K., McCarthy, J. B., Mallamo, J., Ojima, I., & Del Poeta, M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01719-20 · Cited by 124
Regulation of Sterol Biosynthesis in the Human Fungal Pathogen Aspergillus fumigatus: Opportunities for Therapeutic Development
Dhingra, S., & Cramer, R. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00092 · Cited by 116
Polyene antibiotic that inhibits membrane transport proteins
Welscher, Y. M. T., van Leeuwen, M. R., KRUIJFF, B. D., Dijksterhuis, J., & Breukink, E. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203375109 · Cited by 111
C2′-OH of Amphotericin B Plays an Important Role in Binding the Primary Sterol of Human Cells but Not Yeast Cells
Wilcock, B. C., Endo, M. M., Uno, B. E., & Burke, M. D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403255s · Cited by 117
Self-citation
Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries
No, J. H. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.12.016 · Cited by 111
Application of isothermal titration calorimetry as a tool to study natural product interactions
Callies, O., & Daranas, A. H. (2016) · Natural Product Reports · doi:10.1039/c5np00094g · Cited by 109
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal
Maji, A., Soutar, C. P., Zhang, J., Lewandowska, A., Uno, B. E., Su, Y. R., Shelke, Y. G., Murhade, G. M., Nimerovsky, E., Borcik, C. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06710-4 · Cited by 108
Self-citation
Radical Instability in Aid of Efficiency: A Powerful Route to Highly Functional MIDA Boronates
Quiclet‐Sire, B., & Zard, S. Z. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03893 · Cited by 106
Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia
Muraglia, K. A., Chorghade, R. S., Kim, B. R., Tang, X. X., Shah, V. S., Grillo, A. S., Daniels, P. N., Cioffi, A. G., Karp, P. H., Zhu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1018-5 · Cited by 109
Self-citation
Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections
Lakhani, P. M., Patil, A., & Majumdar, S. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0089 · Cited by 105
A Decade of Antifungal Leads from Natural Products: 2010–2019
Aldholmi, M., Marchand, P., Ourliac‐Garnier, I., Pape, P. L., & Ganesan, A. (2019) · Pharmaceuticals · doi:10.3390/ph12040182 · Cited by 102
Biological activity of synthetic ionophores: ion transporters as prospective drugs?
Alfonso, I., & Quesada, R. (2013) · Chemical Science · doi:10.1039/c3sc50882j · Cited by 101
Copper at the Fungal Pathogen-Host Axis
García‐Santamarina, S., & Thiele, D. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.649129 · Cited by 100
Catalytic Site-Selective Thiocarbonylations and Deoxygenations of Vancomycin Reveal Hydroxyl-Dependent Conformational Effects
Fowler, B. S., Laemmerhold, K. M., & Miller, S. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302692j · Cited by 97
The pore-forming action of polyenes: From model membranes to living organisms
Kristanc, L., Božič, B., Jokhadar, Š. Z., Dolenc, M. S., & Gomišček, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.11.006 · Cited by 99
Nontoxic antimicrobials that evade drug resistance
Davis, S. A., Vincent, B. M., Endo, M. M., Whitesell, L. J., Marchillo, K., Andes, D. R., Lindquist, S. L., & Burke, M. D. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1821 · Cited by 94
Self-citation
A polyene macrolide targeting phospholipids in the fungal cell membrane
Deng, Q., Li, Y., He, W., Chen, T., Liu, N., Ma, L., Qiu, Z., Shang, Z., & Wang, Z. (2025) · Nature · doi:10.1038/s41586-025-08678-9 · Cited by 98
Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in ERG2
Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90
Sphingolipids as Targets for Treatment of Fungal Infections
Rollin‐Pinheiro, R., Singh, A., Barreto‐Bergter, E., & Poeta, M. D. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0053 · Cited by 96
Drug Resistance in Leishmaniasis: Current Drug-Delivery Systems and Future Perspectives
Yasinzai, M., Khan, M., Nadhman, A., & Shahnaz, G. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.143 · Cited by 88
Structure-Antifungal Activity Relationships of Polyene Antibiotics of the Amphotericin B Group
Tevyashova, A. N., Olsufyeva, E. N., Solovieva, S. E., Printsevskaya, S. S., Reznikova, M. I., Trenin, A. S., Галатенко, О. А., Treshalin, I. D., Переверзева, Э. Р., Павловна, М. Е., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00270-13 · Cited by 88
Cell Wall changes in amphotericin B-resistant strains from Candida tropicalis and relationship with the immune responses elicited by the host
Mesa-Arango, A. C., Rueda, C., Román, E., Quintin, J., Terrón, M. C., Luque, D., Netea, M. G., Pla, J., & Zaragoza, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-15 · Cited by 86
Antioxidant Properties of Ergosterol and Its Role in Yeast Resistance to Oxidation
Dupont, S., Fleurat‐Lessard, P., da Cruz, R. G., Lafarge, C., Grangeteau, C., Yahou, F., Gerbeau‐Pissot, P., Abrahão, O., Gervais, P., Simon-Plas, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10071024 · Cited by 92
Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound
Sanchez, D. A., Schairer, D. O., Tuckman-Vernon, C., Chouake, J. S., Kutner, A. J., Makdisi, J., Friedman, J. M., Nosanchuk, J. D., & Friedman, A. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.002 · Cited by 85
Toxicity and biochemical action of the antibiotic fungicide tetramycin on Colletotrichum scovillei
Gao, Y., He, L., Li, X., Lin, J., Mu, W., & Liu, F. (2018) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2018.02.012 · Cited by 84
New Insight into Amphotericin B Resistance in Aspergillus terreus
Blum, G., Hörtnagl, C., Jukic, E., Erbeznik, T., Pümpel, T., Dietrich, H., Nagl, M., Speth, C., Rambach, G., & Lass‐Flörl, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01283-12 · Cited by 84
Recent Advances in Boron‐Substituted 1,3‐Dienes Chemistry: Synthesis and Application
Pyziak, J., Walkowiak, J., & Marciniec, B. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602124 · Cited by 83
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
Adler‐Moore, J., Lewis, R. E., Brüggemann, R. J. M., Rijnders, B. J. A., Groll, A. H., & Walsh, T. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz064 · Cited by 85
Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
Lo, W.-H., Deng, F.-S., Chang, C., & Lin, C. (2020) · Molecules · doi:10.3390/molecules25215114 · Cited by 90
The wide-Ranging phenotypes of ergosterol biosynthesis mutants, and implications for microbial cell factories
Johnston, E. J., Moses, T., & Rosser, S. J. (2020) · Yeast · doi:10.1002/yea.3452 · Cited by 74
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing
Braga, S. S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111660 · Cited by 79
Impediment to growth and yeast-to-hyphae transition in Candida albicans by copper oxide nanoparticles
Padmavathi, A. R., Sriyutha Murthy, P., Das, A., Priya, A., Sushmitha, T. J., Pandian, S. K., & Rao, T. S. (2020) · Biofouling · doi:10.1080/08927014.2020.1715371 · Cited by 81
Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis
Sosa, L., Clares, B., Alvarado, H. L., Bozal, N., Domènech, Ò., & Calpena, A. C. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.06.021 · Cited by 79
Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells
Dias, J. D. N., de-Souza-Silva, C. M., de Araújo, A. R., Souza, J. M. T., Júnior, P. H. D. H. V., Cabral, W. F., da Silva, M. D. G., Eaton, P. J., Leite, J. R. S. A., Nicola, A. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67041-2 · Cited by 79
Aspergillus terreus: Novel lessons learned on amphotericin B resistance
Posch, W., Blatzer, M., Wilflingseder, D., & Lass‐Flörl, C. (2018) · Medical Mycology · doi:10.1093/mmy/myx119 · Cited by 74
Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity
Tutaj, K., Szlązak, R., Szałapata, K., Starzyk, J., Luchowski, R., Grudziński, W., Osińska‐Jaroszuk, M., Jarosz‐Wilkołazka, A., Szuster‐Ciesielska, A., & Gruszecki, W. I. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.378 · Cited by 71
Catalyst-Directed Diastereoselective Isomerization of Allylic Alcohols for the Stereoselective Construction of C(20) in Steroid Side Chains: Scope and Topological Diversification
Li, H., & Mazet, C. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06281 · Cited by 70
Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
Loo, A. S., Muhsin, S. A., & Walsh, T. J. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827168 · Cited by 70
Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections
Scarsini, M., Tomasinsig, L., Arzese, A., D’Este, F., Oro, D., & Skerlavaj, B. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.023 · Cited by 70
A Functional Variomics Tool for Discovering Drug-Resistance Genes and Drug Targets
Huang, Z., Chen, K., Zhang, J., Li, Y., Wang, H., Cui, D., Tang, J., Liu, Y., Shi, X., Li, W., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.019 · Cited by 68
Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
Wambaugh, M. A., Denham, S. T., Ayala, M., Brammer, B., Stonhill, M. A., & Brown, J. C. (2020) · eLife · doi:10.7554/elife.54160 · Cited by 65
Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress
Yun, D. G., & Lee, D. G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.01.009 · Cited by 67
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
Cuddihy, G., Wasan, E. K., Di, Y., & Wasan, K. M. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030099 · Cited by 69
Site‐Differentiated Polyboron Arenes Prepared by Direct CH Borylation and Their Highly Selective Suzuki–Miyaura Cross‐Coupling Reactions
Xu, L., Ding, S., & Li, P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309546 · Cited by 66
Sphingolipid Biosynthetic Pathway Genes FEN1 and SUR4 Modulate Amphotericin B Resistance
Sharma, S., Alfatah, Bari, V. K., Rawal, Y., Paul, S. K., & Ganesan, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02130-13 · Cited by 68
ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection
Zhou, Y., Liao, M., Zhu, C., Hu, Y. H., Tong, T., Peng, X., Li, M., Feng, M., Cheng, L., Ren, B., et al. (2018) · International Journal of Oral Science · doi:10.1038/s41368-018-0013-2 · Cited by 69
Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity
Kumar, P., Shivam, P., Mandal, S., Prasanna, P., Kumar, S., Prasad, S. R., Kumar, A., Das, P., Ali, V., Singh, S. K., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s196421 · Cited by 67
Image‐Based Morphological Profiling Identifies a Lysosomotropic, Iron‐Sequestering Autophagy Inhibitor
Laraia, L., Garivet, G., Foley, D. J., Kaiser, N., Müller, S., Zinken, S., Pinkert, T., Wilke, J., Corkery, D., Pahl, A., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201913712 · Cited by 61
Sophorolipid exhibits antifungal activity by ROS mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways in Candida albicans
Haque, F., Verma, N. K., Alfatah, M., Bijlani, S., & Bhattacharyya, M. S. (2019) · RSC Advances · doi:10.1039/c9ra07599b · Cited by 67
Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets
Schneidewind, T., Brause, A., Pahl, A., Burhop, A., Mejuch, T., Sievers, S., Waldmann, H., & Ziegler, S. (2020) · ChemBioChem · doi:10.1002/cbic.202000381 · Cited by 65
Synthesis of trans-2-(Trifluoromethyl)cyclopropanes via Suzuki Reactions with an N-Methyliminodiacetic Acid Boronate
Duncton, M. A. J., & Singh, R. (2013) · Organic Letters · doi:10.1021/ol401636d · Cited by 65
Self-Association of Amphotericin B: Spontaneous Formation of Molecular Structures Responsible for the Toxic Side Effects of the Antibiotic
Starzyk, J., Gruszecki, M., Tutaj, K., Luchowski, R., Szlązak, R., Waśko, P., Grudziński, W., Czub, J., & Gruszecki, W. I. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp510245n · Cited by 64
Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
New antifungal strategies: Drug combination and co-delivery
Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63
Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe
Francesco, M. A. D. (2023) · Pathogens · doi:10.3390/pathogens12111305 · Cited by 69

Authors: Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D.
Affiliations: Howard Hughes Medical Institute (US)
ORCID: Gray, Kaitlyn C.
Palacios, Daniel S.
Burke, Martin D.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2012-01-17
Volume: 109
Issue: 7
Pages: 2234-2239
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1117280109
PMC: PMC3289339
OpenAlex: W1987640473
Cited by: 608
References: 50
Citations by year: 2026: 42 · 2025: 42 · 2024: 34 · 2023: 49 · 2022: 45 · 2021: 56 · 2020: 53 · 2019: 50 · 2018: 32 · 2017: 44 · 2016: 44 · 2015: 40 · 2014: 36 · 2013: 30 · 2012: 11
FWCI: 24.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
Bristol-Myers Squibb
National Institutes of Health
National Institute of General Medical Sciences (R01GM080436, GM080436)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
Keywords: amphotericin B, ergosterol binding, yeast cell death, antifungal mechanism, ion channel formation, membrane permeabilization, fungal drug resistance, natural product derivatives, therapeutic index, antifungal toxicity
MeSH terms: Amphotericin B, Antifungal Agents, Ergosterol, Saccharomyces cerevisiae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amphotericin primarily kills yeast by simply binding ergosterol

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks